ArticleJournal, genetic engineering & biotechnology2026
PIP3 antagonist as a molecular regulator in MSC-derived cardiomyocytes: Potential in vitro therapeutic implications for conotruncal heart defects.
Alaaeldin Fayez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.